These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15576477)

  • 1. Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.
    Muris JJ; Cillessen SA; Vos W; van Houdt IS; Kummer JA; van Krieken JH; Jiwa NM; Jansen PM; Kluin-Nelemans HC; Ossenkoppele GJ; Gundy C; Meijer CJ; Oudejans JJ
    Blood; 2005 Apr; 105(7):2916-23. PubMed ID: 15576477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay.
    Cillessen SA; Meijer CJ; Ossenkoppele GJ; Castricum KC; Westra AH; Niesten P; Muris JJ; Nijdam HF; van der Hem KG; Flens M; Hooijberg E; Oudejans JJ
    Br J Haematol; 2006 Aug; 134(3):283-93. PubMed ID: 16848771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of caspase 9 and not caspase 8 mediated apoptosis may determine clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.
    Oudejans JJ; Muris JJ; Meijer CJ
    Cell Cycle; 2005 Apr; 4(4):526-8. PubMed ID: 15876872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule XIAP antagonist restores caspase-9 mediated apoptosis in XIAP-positive diffuse large B-cell lymphoma cells.
    Cillessen SA; Reed JC; Welsh K; Pinilla C; Houghten R; Hooijberg E; Deurhof J; Castricum KC; Kortman P; Hess CJ; Ossenkoppele GJ; Meijer CJ; Oudejans JJ
    Blood; 2008 Jan; 111(1):369-75. PubMed ID: 17916749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma.
    ten Berge RL; Meijer CJ; Dukers DF; Kummer JA; Bladergroen BA; Vos W; Hack CE; Ossenkoppele GJ; Oudejans JJ
    Blood; 2002 Jun; 99(12):4540-6. PubMed ID: 12036886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and prognostic significance of apoptotic profile in patients with newly diagnosed nodal diffuse large B-cell lymphoma (DLBCL).
    Markovic O; Marisavljevic D; Cemerikic V; Perunicic M; Savic S; Filipovic B; Mihaljevic B
    Eur J Haematol; 2011 Mar; 86(3):246-55. PubMed ID: 21198858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taxol induces caspase-10-dependent apoptosis.
    Park SJ; Wu CH; Gordon JD; Zhong X; Emami A; Safa AR
    J Biol Chem; 2004 Dec; 279(49):51057-67. PubMed ID: 15452117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the intrinsic apoptosis pathway downstream of caspase-9 activation causes chemotherapy resistance in diffuse large B-cell lymphoma.
    Cillessen SA; Hess CJ; Hooijberg E; Castricum KC; Kortman P; Denkers F; Vos W; van de Wiel MA; Schuurhuis GJ; Ossenkoppele GJ; Meijer CJ; Oudejans JJ
    Clin Cancer Res; 2007 Dec; 13(23):7012-21. PubMed ID: 18056177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
    Blood A; Edwards CJ; Ishii HH; Pat BK; Bryson G; Sculley TB; Gobe GC
    Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FADD expression and caspase activation in B-cell lymphomas resistant to Fas-mediated apoptosis.
    Xerri L; Devilard E; Bouabdallah R; Stoppa AM; Hassoun J; Birg F
    Br J Haematol; 1999 Sep; 106(3):652-61. PubMed ID: 10468853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
    Alas S; Ng CP; Bonavida B
    Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-FLIP does not correlate with response to immunochemotherapy treatment and outcome of patients with nodal diffuse large B-cell lymphoma.
    Markovic O; Marisavljevic D; Cemerikic-Martinovic V; Filipovic B; Radovanović S; Zdravković M; Stanisavljevic D; Mihaljevic B
    Biomed Pharmacother; 2013 Jun; 67(5):445-9. PubMed ID: 23582793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S; Meyer E; Debatin KM
    Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis.
    Engels IH; Stepczynska A; Stroh C; Lauber K; Berg C; Schwenzer R; Wajant H; Jänicke RU; Porter AG; Belka C; Gregor M; Schulze-Osthoff K; Wesselborg S
    Oncogene; 2000 Sep; 19(40):4563-73. PubMed ID: 11030145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma.
    Muris JJ; Meijer CJ; Vos W; van Krieken JH; Jiwa NM; Ossenkoppele GJ; Oudejans JJ
    J Pathol; 2006 Apr; 208(5):714-23. PubMed ID: 16400625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of XIAP expression in DLBCL and effect of its inhibition on AKT signalling.
    Hussain AR; Uddin S; Ahmed M; Bu R; Ahmed SO; Abubaker J; Sultana M; Ajarim D; Al-Dayel F; Bavi PP; Al-Kuraya KS
    J Pathol; 2010 Oct; 222(2):180-90. PubMed ID: 20632385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of caspase-8 is critical for sensitivity to cytotoxic anti-Fas antibody-induced apoptosis in human ovarian cancer cells.
    Hayakawa A; Wu J; Kawamoto Y; Zhou YW; Tanuma S; Nakashima I; Suzuki H
    Apoptosis; 2002 Apr; 7(2):107-13. PubMed ID: 11865194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis.
    Chawla-Sarkar M; Bae SI; Reu FJ; Jacobs BS; Lindner DJ; Borden EC
    Cell Death Differ; 2004 Aug; 11(8):915-23. PubMed ID: 15118763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2.
    Poulaki V; Mitsiades N; Romero ME; Tsokos M
    Cancer Res; 2001 Jun; 61(12):4864-72. PubMed ID: 11406564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors.
    Djerbi M; Screpanti V; Catrina AI; Bogen B; Biberfeld P; Grandien A
    J Exp Med; 1999 Oct; 190(7):1025-32. PubMed ID: 10510092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.